Royal London Asset Management
CRL icon

Royal London Asset Management’s Charles River Laboratories CRL Stock Holding History

Royal London Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,278
Closed -$343K – 725
2025
Q1 		$343K Sell
2,278
-14,147
-86% -$2.37M ﹤0.01% 708
2024
Q4 		$3.03M Buy
16,425
+991
+6% +$191K 0.01% 583
2024
Q3 		$3.04M Sell
15,434
-33
-0.2% -$6.86K 0.01% 588
2024
Q2 		$3.2M Hold
15,467
– – 0.01% 589
2024
Q1 		$4.19M Sell
15,467
-440
-3% -$105K 0.01% 573
2023
Q4 		$3.76M Sell
15,907
-305
-2% -$60K 0.01% 582
2023
Q3 		$3.18M Hold
16,212
– – 0.01% 595
2023
Q2 		$3.41M Hold
16,212
– – 0.01% 576
2023
Q1 		$3.27M Sell
16,212
-341
-2% -$77.3K 0.01% 559
2022
Q4 		$3.6M Hold
16,553
– – 0.02% 531
2022
Q3 		$3.26M Sell
16,553
-1,153
-7% -$249K 0.02% 538
2022
Q2 		$3.79M Buy
17,706
+616
+4% +$151K 0.02% 521
2022
Q1 		$4.85M Buy
17,090
+4,784
+39% +$1.48M 0.02% 508
2021
Q4 		$4.64M Buy
12,306
+8,958
+268% +$3.48M 0.02% 512
2021
Q3 		$1.38M Buy
+3,348
New +$1.39M 0.01% 635

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Royal London Asset Management's CRL Position: Q2 2025 in Review

Royal London Asset Management sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 2,278 shares — an estimated $343K sold.

Royal London Asset Management first reported a position in CRL in Q3 2021 and held it in 15 quarters. The position peaked at $4.85M in Q1 2022. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Royal London Asset Management reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Royal London Asset Management sold 2,278 Charles River Laboratories shares in Q2 2025, an estimated $343K.
  • Royal London Asset Management first reported a position in Charles River Laboratories in Q3 2021 and held it in 15 quarters.
  • Royal London Asset Management's Charles River Laboratories position peaked at $4.85M in Q1 2022.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Royal London Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.